Literature DB >> 18683471

Physiology and pathophysiology of the vasopressinergic system.

Jean-Louis Vincent1, Fuhong Su.   

Abstract

Arginine vasopressin, a hypothalamic peptide hormone, has multiple physiological functions, including body water regulation, control of blood pressure and effects on body temperature, insulin release, corticotropin release, memory and social behaviour. These functions are achieved via at least three specific G-protein-coupled vasopressin receptors. Development of specific vasopressin receptor antagonists in recent years is helping to elucidate the precise actions of vasopressin at each of these receptor types. The complex signalling and messenger processes which take place after receptor stimulation are now more clearly understood. Vasopressin dysregulation can occur in various disease processes, and a better understanding of the mechanisms underlying physiological synthesis, release and regulation of vasopressin will help in the development of therapies to treat these conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683471     DOI: 10.1016/j.bpa.2008.03.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  10 in total

Review 1.  Anesthetic Management of the Hypertensive Patient: Part I.

Authors:  Russell Yancey
Journal:  Anesth Prog       Date:  2018

2.  Plasma vasopressin and interpersonal functioning.

Authors:  Jean-Philippe Gouin; C Sue Carter; Hossein Pournajafi-Nazarloo; William B Malarkey; Timothy J Loving; Jeffrey Stowell; Janice K Kiecolt-Glaser
Journal:  Biol Psychol       Date:  2012-07-20       Impact factor: 3.251

3.  Effect of adding vasopressin on the distribution of lidocaine in tissues, anesthetic action, and circulatory dynamics.

Authors:  Naoko Murata; Katsuhisa Sunada; Shuichi Hashimoto
Journal:  Odontology       Date:  2019-08-26       Impact factor: 2.634

4.  Mass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processing.

Authors:  Nitin Gupta; Steven J Bark; Weiya D Lu; Laurent Taupenot; Daniel T O'Connor; Pavel Pevzner; Vivian Hook
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

5.  Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices.

Authors:  Annette D Rieg; Rolf Rossaint; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

Review 6.  Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials.

Authors:  Andrea Pasquale Cossu; Paolo Mura; Lorenzo Matteo De Giudici; Daniela Puddu; Laura Pasin; Maurizio Evangelista; Theodoros Xanthos; Mario Musu; Gabriele Finco
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

7.  Prolonged urinary leakage in the postoperative period of renal hydatic cyst treatment with oral desmopressin: a case report.

Authors:  Cavit Ceylan; Ozkan Baytok; Serkan Doğan; Metin Yığman
Journal:  J Med Case Rep       Date:  2012-10-05

8.  A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.

Authors:  Xinrong He; Fuhong Su; Fabio Silvio Taccone; Régent Laporte; Anne Louise Kjølbye; Jing Zhang; Keliang Xie; Mouhamed Djahoum Moussa; Torsten Michael Reinheimer; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

9.  A Rare Case of Central Pontine Myelinolysis in Overcorrection of Hyponatremia with Total Parenteral Nutrition in Pregnancy.

Authors:  Kalyana C Janga; Tazleem Khan; Ciril Khorolsky; Sheldon Greenberg; Priscilla Persaud
Journal:  Case Rep Nephrol       Date:  2015-12-22

Review 10.  Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions.

Authors:  Olivier Lesur; Eugénie Delile; Pierre Asfar; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2018-10-29       Impact factor: 6.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.